Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alexandra Balcom currently holds 11,050 shares of Nuvalent, Inc. (NUVL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alexandra Balcom has been a net seller of NUVL stock. They have purchased $0 and sold $19.0M worth of shares.
Alexandra Balcom's most recent insider trade was on Jun 2, 2026, when they sold 11,050 shares at $0.00 per share.
Alexandra Balcom serves as Executive at Nuvalent, Inc. (NUVL). They have executed 69 insider transactions totaling $19.0M over their tenure at the company.
Alexandra Balcom holds the position of Executive at Nuvalent, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Alexandra Balcom has shown a selling trading pattern, with $0 in total purchases and $19.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alexandra Balcom was on Sep 30, 2025, when they sold $1.7M worth of NUVL shares. This transaction involved 20,000 shares at $85.06 per share.
Alexandra Balcom currently owns 11,050 shares of Nuvalent, Inc. (NUVL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alexandra Balcom's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alexandra Balcom has 69 Form 4 filings on record as an insider at Nuvalent, Inc..
Set alerts for Alexandra Balcom and 40,000+ other insiders.